A Global Perspective & Cross-Cultural Fluency

I benefited from the French educational model which emphasizes a broad, multidisciplinary foundation spanning both scientific and non-scientific domains up to age 18, followed by broad scientific university training encompassing mathematics, computing, physics, chemistry, and biology well into Master's level studies. This broad curriculum provides a uniquely versatile framework, enabling me to fluidly interact with specialists across diverse domains and effectively bridge the gap between preclinical scientists, clinical operations teams, and commercial stakeholders.

This multidisciplinary foundation is complemented by advanced academic training from a top-tier European university, with a PhD in Organic Chemistry from the University of Oxford. This combination ensures a uniquely broad yet deeply analytical approach when evaluating complex data packages, trial designs, and regulatory dossiers.

Building upon these roots, my career spans professional leadership roles across the UK, the US, Australia, Switzerland, and France alongside daily collaboration with cross-functional teams in India, China, and broader Asia. This multicultural exposure allows me to navigate diverse environments and align stakeholders seamlessly, regardless of geography or organizational culture.


Track Record of Multi-Dimensional Delivery

My career reflects a rare breadth of exposure across large pharmaceutical companies, biotech, not-for-profit organizations, contract research organizations (CROs), and international product development partnerships—giving me a deep, first-hand understanding of the unique bottlenecks, regulatory nuances, and operational pressures clients face at every stage.

End-to-End Clinical Execution

Novotech, Brisbane | 2021–2026
  • Delivered 7 Phase 1 studies (including First-in-Human) from kick-off to closeout, managing complex adaptive designs, strict timelines, and multi-regional CTA/ethics submissions across Australia and New Zealand.

Specialized Complex Clinical Trials

QIMR Berghofer, Brisbane | 2018–2020
  • Led complex human challenge studies requiring rigorous real-time safety monitoring, rapid clinical intervention, and the implementation of a custom cross-study tracking database to monitor participant responses.

Preclinical & Translational Strategy

MMV, Geneva | 2014–2017
  • Leveraged deep expertise in preclinical-to-early-clinical translation to define development paths for therapeutics, orchestrating rigorous CRO oversight and defending program strategies before external expert committees and governance boards.

Early-Phase & Discovery Leadership

EMD Serono / Merck Serono, Boston & Geneva | 2009–2013
  • Managed multi-disciplinary discovery and early development teams, coupling project management discipline with custom-built operational software tools.

Core Credentials & Qualifications

  • Doctor of Philosophy (PhD) in Organic Chemistry — University of Oxford, UK
  • Master & Bachelor in Chemistry — Blaise Pascal University, France
  • Project Management Professional (PMP) — Project Management Institute (PMI)